The Dexcom lawsuit in 2026 centers on claims that Dexcom’s continuous glucose monitors gave dangerously inaccurate readings. Those readings allegedly caused real harm, from insulin dosing errors to emergency hospitalizations.
If you relied on a Dexcom G6 or G7 and experienced a malfunction, you may have a legal claim worth pursuing this year. Thousands of FDA adverse event reports back up what patients have been saying for years.
This article breaks down every angle of the litigation. You’ll find settlement estimates, eligibility requirements, filing steps, and the latest 2026 case updates. Over 25,000 adverse event reports tied to Dexcom devices sit in the FDA’s MAUDE database as of early 2026.
That number keeps growing. So does the legal pressure on Dexcom Inc.
Dexcom Lawsuit
The Dexcom lawsuit refers to legal claims filed against Dexcom Inc. by patients who say the company’s CGM devices malfunctioned, gave false readings, or caused physical injuries. These claims fall under product liability law, and they target both the design and manufacturing of Dexcom’s sensors.
At the heart of every case is a simple accusation: Dexcom sold a medical device that didn’t work as promised. Patients trusted those glucose numbers to make life-or-death insulin decisions.
When the readings were wrong, the consequences were severe. Some people experienced dangerous hypoglycemia. Others went into diabetic ketoacidosis because their device showed normal glucose levels while their actual blood sugar was spiking.
| Key Fact | Detail |
|---|---|
| Defendant | Dexcom Inc. (San Diego, CA) |
| Devices Named | Dexcom G6, Dexcom G7 |
| Legal Theory | Product liability, negligence, failure to warn |
| Primary Allegation | Inaccurate glucose readings causing harm |
| Status | Active litigation, individual and group claims |
Dexcom generates billions in annual revenue from these devices. The company has positioned itself as the gold standard in glucose monitoring. But lawsuits allege that marketing outpaced actual device reliability.
The stakes are personal for every claimant. These aren’t gadgets. They’re medical devices people depend on 24 hours a day.
Dexcom Lawsuit 2026
The Dexcom lawsuit in 2026 is gaining momentum as more plaintiffs join the litigation and courts begin organizing cases for potential coordinated proceedings. This year marks a turning point because the volume of claims has grown large enough to attract judicial attention for possible consolidation.
Several factors make 2026 a pivotal year. New FDA adverse event data published in late 2025 added fresh fuel to existing claims. Attorneys across the country are now actively reviewing cases and building plaintiff groups.
Courts may decide in 2026 whether to consolidate Dexcom cases into multidistrict litigation. That decision would streamline discovery and speed up the overall process for everyone involved.
- More law firms are accepting Dexcom cases in 2026 than in any previous year
- FDA MAUDE database reports for Dexcom devices surpassed 25,000 entries
- Bellwether trial selections could begin if MDL status is granted
- Expert witnesses in medical device engineering are being retained by plaintiff counsel
If you’ve been waiting to act, 2026 is the year to pay attention. Statutes of limitations vary by state, and some deadlines are approaching fast. The legal window won’t stay open forever.
Think of it like a train leaving the station. Each month that passes, your options narrow.
Dexcom Lawsuit Update 2026
The latest Dexcom lawsuit update for 2026 shows that litigation is actively progressing in multiple federal and state courts. No global settlement has been reached, but pretrial motions and discovery phases are underway in several key cases.
Here’s where things stand right now:
| Milestone | Status (2026) |
|---|---|
| MDL Consolidation Request | Under judicial review |
| Individual State Cases | Active in CA, TX, FL, IL, NY |
| Discovery Phase | Ongoing in lead cases |
| Bellwether Trial Selection | Expected mid to late 2026 |
| Global Settlement | Not yet proposed |
| New Case Filings | Increasing monthly |
Dexcom’s legal team has filed motions to dismiss in several jurisdictions. So far, judges have allowed most claims to move forward. That’s a positive sign for plaintiffs.
Internal Dexcom documents are being requested through discovery. These could reveal what the company knew about device accuracy problems and when they knew it. That evidence often becomes the backbone of product liability cases.
No settlement talks have been publicly confirmed. But experienced mass tort attorneys say the pace of filings often pushes defendants to the negotiating table within 12 to 18 months of consolidation.
Key Takeaway: The Dexcom lawsuit is actively growing in 2026, with courts organizing cases, discovery progressing, and new filings arriving every month.
Dexcom Class Action Lawsuit
A Dexcom class action lawsuit would allow a large group of affected users to sue Dexcom together as one unified case. As of early 2026, no certified class action exists at the federal level, but the legal groundwork is being laid.
Class actions and mass torts work differently, and it matters which path this litigation takes.
| Feature | Class Action | Mass Tort (MDL) |
|---|---|---|
| How Claims Are Handled | One case represents all plaintiffs | Individual cases grouped together |
| Payout Structure | Equal or tiered for all members | Based on individual damages |
| Plaintiff Involvement | Minimal after joining | More active role required |
| Speed | Often faster to settle | Can take longer but yields higher payouts |
| Common In | Consumer fraud, overcharging | Medical device injuries, personal injury |
Right now, Dexcom claims are trending toward mass tort or MDL treatment rather than a traditional class action. That’s because injuries vary widely from person to person. One plaintiff might have a skin reaction. Another might have been hospitalized for diabetic ketoacidosis.
The distinction matters for your wallet. In a mass tort, your compensation reflects your specific injuries. In a class action, everyone typically gets the same amount or a formula-based share.
Some state-level class actions related to consumer fraud or deceptive marketing of Dexcom devices could still emerge. These would focus on financial harm rather than physical injuries.
Dexcom G6 Lawsuit
The Dexcom G6 lawsuit focuses on the company’s sixth-generation continuous glucose monitor, which launched in 2018 and became widely used by millions of diabetic patients. Plaintiffs allege this device had persistent accuracy issues and sensor failures.
Reported problems with the G6 include:
- Sensors giving falsely low glucose readings, triggering unnecessary insulin doses
- Sensors giving falsely high readings, causing patients to skip needed insulin
- Complete signal loss during critical monitoring periods
- Sensor adhesive causing burns, rashes, and allergic reactions
- Transmitter disconnections from the sensor pod
The G6 was marketed as a “no fingerstick” device. That promise carried enormous weight. Patients stopped doing manual blood sugar checks because they trusted the G6’s real-time data.
When that data was wrong, patients had no backup warning system. It’s like removing the guardrails on a mountain road and telling drivers the GPS will keep them safe.
| G6 Issue | Reported Consequence |
|---|---|
| False low reading | Hypoglycemia from unnecessary insulin |
| False high reading | Hyperglycemia, potential DKA |
| Signal dropout | Hours without glucose data |
| Adhesive reaction | Chemical burns, scarring |
| Transmitter failure | Complete loss of monitoring |
FDA reports show thousands of G6-specific adverse events. Many involved emergency room visits. Some required hospitalization for multiple days.
Dexcom G7 Lawsuit
The Dexcom G7 lawsuit targets the company’s newest CGM model, released in 2022, which Dexcom promoted as a major upgrade over the G6. Despite the improvements in size and warm-up time, plaintiffs report the G7 shares many of the same accuracy problems.
G7 complaints filed with the FDA include inaccurate readings during the first 24 hours of sensor wear, sudden sensor failures mid-session, and Bluetooth connectivity issues that left patients without real-time data.
The G7’s smaller form factor may have introduced new engineering challenges. A smaller sensor housing means tighter tolerances and potentially less reliable adhesion and signal transmission.
- G7 sensors have a 10-day wear period compared to the G6’s 10-day period
- Warm-up time dropped to 30 minutes from the G6’s 2 hours
- But accuracy complaints during warm-up remain high
- Adhesive failures seem to occur more frequently with the G7’s smaller patch
Patients who switched from the G6 to the G7 expecting better performance found similar or even new problems. That pattern strengthens the argument that Dexcom has a systemic quality control issue, not just a one-model defect.
Some G7 lawsuits also target Dexcom’s marketing claims. The company advertised the G7 as its “most accurate sensor ever.” Plaintiffs argue that claim was misleading given the volume of adverse reports.
Key Takeaway: Both the Dexcom G6 and G7 face serious legal claims in 2026, with thousands of FDA adverse event reports documenting inaccurate readings, sensor failures, and adhesive injuries.
Dexcom Device Malfunction Lawsuit
The Dexcom device malfunction lawsuit category covers all claims where the CGM hardware or software failed to perform as intended. This goes beyond just inaccurate readings. It includes total device failures, app crashes, and integration breakdowns with insulin pumps.
A CGM is part of a connected medical ecosystem. When one piece fails, the whole chain breaks.
Here are the most commonly reported malfunctions:
| Malfunction Type | What Happens | Risk Level |
|---|---|---|
| Sensor failure | Device stops reading glucose entirely | High |
| App crash | Patient loses access to real-time data | Medium to High |
| Bluetooth disconnect | Sensor and phone stop communicating | Medium |
| Insulin pump integration error | Wrong glucose data sent to automated pump | Critical |
| Calibration drift | Readings slowly become inaccurate over days | High |
The insulin pump integration issue is particularly alarming. Devices like the Tandem t:slim X2 use Dexcom data to automatically adjust insulin delivery. If Dexcom sends a wrong number, the pump delivers the wrong dose.
That’s not a minor inconvenience. That’s a potentially life-threatening chain reaction triggered by a single faulty sensor reading.
Plaintiffs in malfunction cases often have strong evidence. Most Dexcom devices and apps store logs of readings, alerts, and connectivity events. That digital trail can prove exactly when and how the device failed.
Dexcom Recall Lawsuit
The Dexcom recall lawsuit centers on instances where Dexcom issued product recalls or safety alerts but allegedly failed to act quickly enough or broadly enough to protect patients. Several Dexcom recalls have occurred over the past few years.
Notable Dexcom recalls include:
- November 2020: Dexcom recalled certain G6 sensors due to potential for inaccurate readings during the first day of use
- 2021: The FDA classified certain Dexcom issues as Class I recalls, the most serious category
- 2023: Additional sensor lots recalled for potential premature failure
A Class I recall means the FDA determined there was a “reasonable probability that use of the product will cause serious adverse health consequences or death.” That language is about as urgent as it gets in medical device regulation.
| Recall Detail | Info |
|---|---|
| Most Serious Classification | Class I (life-threatening risk) |
| Products Affected | Specific G6 sensor lots |
| Reason | Inaccurate first-day readings, premature sensor failure |
| Dexcom Response | Replacement sensors shipped, software updates issued |
| Plaintiff Argument | Recall was too slow and too narrow |
Lawsuit claims argue Dexcom knew about these problems before the recalls were issued. Internal testing data and complaint logs could show the company waited too long to pull defective products from the market.
If you used a recalled Dexcom sensor and were injured, that recall itself becomes powerful evidence in your case. It shows even Dexcom admitted the product was dangerous.
Dexcom FDA Complaints
Dexcom FDA complaints are adverse event reports submitted by patients, healthcare providers, and Dexcom itself to the FDA’s MAUDE database. Over 25,000 reports related to Dexcom CGM devices appear in this database as of early 2026.
These reports document real incidents. Real injuries. Real device failures.
Common themes across FDA complaints include:
- Glucose readings off by 50 mg/dL or more compared to fingerstick tests
- Sensors that stopped working mid-wear cycle
- Emergency room visits caused by insulin dosing based on faulty CGM data
- Skin injuries from adhesive components
- Deaths reported in connection with CGM device reliance
The MAUDE database is publicly searchable. Anyone can look up Dexcom-related reports. Attorneys use this data to establish a pattern of problems that goes beyond isolated incidents.
| MAUDE Data Point | Approximate Count |
|---|---|
| Total Dexcom adverse event reports | 25,000+ |
| Reports involving hospitalization | 3,000+ |
| Reports involving life-threatening events | 500+ |
| Reports mentioning inaccurate readings | 10,000+ |
| Reports involving skin/adhesive injuries | 4,000+ |
These numbers tell a story that individual anecdotes cannot. They show a pattern. Patterns matter in product liability cases because they undermine any defense that injuries were random or user error.
When thousands of people report the same problem with the same device, it becomes very hard for the manufacturer to argue the product was safe and effective.
Key Takeaway: Over 25,000 FDA adverse event reports for Dexcom devices create a powerful evidence base for lawsuits, showing a clear pattern of device failures and patient injuries.
Dexcom CGM Lawsuit
The Dexcom CGM lawsuit is the broadest label for all legal claims against Dexcom’s continuous glucose monitoring product line. It encompasses G6, G7, and older model claims under the umbrella of CGM technology failure.
CGM devices changed diabetes management. Before them, patients had to prick their fingers multiple times daily. Dexcom promised a better way: a tiny sensor under the skin, continuous readings on a phone, and peace of mind.
That promise made patients dependent on Dexcom data. And that dependency is exactly what makes the failures so dangerous.
- Patients with Type 1 diabetes rely on CGM data to calculate every insulin dose
- Parents monitor children’s glucose levels overnight through CGM apps
- Some patients use Dexcom CGMs integrated with automated insulin delivery systems
- Athletes and active users depend on real-time glucose data during physical activity
The CGM lawsuit argues Dexcom created a product that people trusted with their lives, then failed to ensure that product met the standard of care expected of a life-sustaining medical device.
Unlike a fitness tracker that gives a bad step count, a CGM that gives a bad glucose number can directly cause a medical emergency. The legal standard for accuracy and reliability is supposed to be much higher for Class II medical devices like the Dexcom CGM.
Dexcom Product Liability
Dexcom product liability claims are built on the legal principle that manufacturers are responsible for injuries caused by defective products. In Dexcom’s case, plaintiffs argue the company is liable under three distinct theories.
| Liability Theory | What It Means |
|---|---|
| Design Defect | The CGM design itself is flawed, making all units potentially dangerous |
| Manufacturing Defect | Certain batches or lots were improperly made |
| Failure to Warn | Dexcom didn’t adequately warn users about known accuracy limitations |
Each theory requires different evidence. Design defect claims need expert testimony showing a safer alternative design existed. Manufacturing defect claims focus on quality control breakdowns. Failure to warn claims examine Dexcom’s user manuals, marketing, and FDA labeling.
Most Dexcom lawsuits combine all three theories. That strategy gives plaintiffs multiple paths to prove their case.
Product liability law in most states uses a “strict liability” standard for medical devices. That means plaintiffs don’t always have to prove Dexcom was negligent. They only have to prove the product was defective and caused harm.
That’s a lower bar to clear than a standard negligence case. It puts the burden on Dexcom to defend the safety of their product rather than forcing patients to prove the company was careless.
The strict liability approach makes these cases more accessible for everyday people who were hurt by a device they trusted.
Dexcom Lawsuit Eligibility
Dexcom lawsuit eligibility depends on three main factors: which device you used, what happened to you, and when it occurred. Not everyone who owns a Dexcom qualifies, but the criteria are broader than most people expect.
You may be eligible if you meet these conditions:
- You used a Dexcom G6 or G7 CGM device
- You experienced inaccurate readings confirmed by fingerstick or lab test
- The inaccurate reading led to a medical event (hypoglycemia, hyperglycemia, DKA, ER visit, hospitalization)
- You suffered a physical injury from the sensor or adhesive (burns, scarring, allergic reaction)
- Your incident occurred within the applicable statute of limitations for your state
| Eligibility Factor | Details |
|---|---|
| Device Model | Dexcom G6 or Dexcom G7 |
| Type of Harm | Physical injury, medical emergency, or documented health complication |
| Evidence Needed | Medical records, device data logs, purchase records |
| Time Limit | Varies by state (typically 2 to 3 years from injury) |
| Who Can File | Patient, parent/guardian of minor, or estate of deceased patient |
You don’t need to have been hospitalized to qualify. Some claims involve documented medical visits, medication adjustments, or even the emotional distress of discovering your life-sustaining device was unreliable.
Having your Dexcom purchase receipts and medical records from the time of injury strengthens your case significantly. Start gathering those documents now.
Who Qualifies for Dexcom Lawsuit
Who qualifies for a Dexcom lawsuit? Any person who used a Dexcom G6 or G7 CGM device and suffered harm due to device malfunction, inaccurate readings, or adhesive-related injuries may have a valid claim.
The qualification process works like a checklist. The more boxes you check, the stronger your case.
Strong Candidates:
- Hospitalized due to insulin dosing based on wrong Dexcom readings
- Diagnosed with diabetic ketoacidosis while wearing a functioning Dexcom sensor
- Suffered severe hypoglycemia because the sensor showed normal glucose levels
- Experienced chemical burns or scarring from the sensor adhesive
- Had a sensor fail during a critical period (overnight, during exercise, while driving)
Moderate Candidates:
- Visited an ER or urgent care due to Dexcom-related blood sugar issues
- Required medication adjustments after discovering persistent inaccuracy
- Reported problems to Dexcom and received a replacement sensor as acknowledgment
May Not Qualify:
- Minor skin irritation that resolved on its own
- Dissatisfaction with the device without documented medical harm
- Problems caused by user error (incorrect insertion, expired sensors)
The line between qualifying and not qualifying often comes down to documentation. If you have medical records showing treatment for an event linked to your CGM, that’s the foundation of your case.
Parents who monitored their children’s glucose with Dexcom devices and had a child experience a medical emergency can also file on behalf of the minor.
Key Takeaway: You may qualify for a Dexcom lawsuit if you used a G6 or G7 device and experienced documented medical harm from inaccurate readings, device failure, or adhesive injuries.
Dexcom Injury Claims
Dexcom injury claims fall into several categories based on the type of harm suffered. Physical injuries range from minor skin reactions to life-threatening metabolic crises. Each type carries different potential compensation value.
| Injury Category | Examples | Severity Rating |
|---|---|---|
| Metabolic Emergency | Diabetic ketoacidosis, severe hypoglycemia | Critical |
| Hospitalization | Multi-day inpatient stay for glucose crisis | Severe |
| Emergency Room Visit | Treatment for acute hypo or hyperglycemia | Moderate to Severe |
| Skin and Tissue Injury | Chemical burns, scarring, infection from adhesive | Moderate |
| Medication Error | Wrong insulin dose based on false readings | Moderate to Severe |
| Wrongful Death | Death attributed to CGM-related insulin error | Maximum |
The most serious claims involve patients who went into DKA, a condition where blood sugar climbs so high the body starts breaking down fat into toxic acids. DKA can cause organ damage, coma, and death.
Hypoglycemia claims are equally dangerous in the opposite direction. When a sensor falsely shows high glucose, a patient may take extra insulin. That extra insulin drops blood sugar to dangerously low levels, causing seizures, loss of consciousness, or worse.
Skin injury claims, while less immediately life-threatening, can still be significant. Some patients report third-degree chemical burns from the adhesive, requiring wound care and leaving permanent scars.
Each injury type requires specific medical documentation. The more detailed your medical records, the stronger your claim and the higher your potential compensation.
Dexcom Lawsuit Settlement
A Dexcom lawsuit settlement has not been finalized as of early 2026, but legal experts anticipate settlement discussions could begin once cases are consolidated and discovery is complete. Settlements in medical device cases typically occur after both sides assess the strength of the evidence.
Here’s how the settlement process usually works in cases like this:
- Cases are filed and begin moving through courts
- MDL consolidation groups cases for efficient pretrial work
- Discovery phase reveals internal company documents and data
- Bellwether trials test a handful of representative cases before juries
- Settlement negotiations begin, often influenced by bellwether outcomes
- Global settlement is proposed, covering most or all plaintiffs
- Claims process opens for qualified plaintiffs to submit documentation
| Settlement Timeline Phase | Estimated Timing |
|---|---|
| MDL Formation | Mid 2026 |
| Discovery Completion | Late 2026 to early 2027 |
| Bellwether Trials | 2027 |
| Settlement Talks | 2027 to 2028 |
| Payouts to Claimants | 2028 or later |
Medical device settlements can take years. The hip implant litigation against DePuy took nearly a decade. The hernia mesh cases dragged on even longer. But some device cases settle faster when the evidence is overwhelming.
Filing your claim now positions you to receive compensation when the settlement does come through. Waiting until a settlement is announced often means missed deadlines or reduced access to funds.
Dexcom Lawsuit Settlement Amounts
Dexcom lawsuit settlement amounts will vary based on injury severity, medical expenses, and the strength of individual claims. While no settlement has been announced yet, projections based on comparable medical device cases provide a reasonable range.
| Injury Level | Estimated Payout Range | Basis for Estimate |
|---|---|---|
| Skin irritation or minor adhesive reaction | $5,000 to $25,000 | Similar consumer device cases |
| ER visit due to inaccurate reading | $25,000 to $75,000 | Comparable CGM/medical device settlements |
| Hospitalization for glucose emergency | $75,000 to $250,000 | Medical device hospitalization precedents |
| ICU stay or organ damage from DKA | $250,000 to $750,000 | Severe injury mass tort precedents |
| Wrongful death | $500,000 to $2,000,000+ | Medical device wrongful death benchmarks |
These numbers are projections, not guarantees. Every case is different. The amount you receive depends on your specific injuries, your medical bills, lost wages, pain and suffering, and the quality of your evidence.
Factors that increase your payout:
- Extended hospital stays with detailed medical records
- Permanent injury or lasting health complications
- Clear device data showing the malfunction
- Evidence that Dexcom was warned about the defect before your injury
- Strong documentation linking the CGM failure to your medical event
Factors that decrease your payout:
- Minimal medical treatment
- No device data or purchase records
- Pre-existing conditions that complicate causation
- Filing close to or past the statute of limitations
Dexcom Lawsuit Payout
Dexcom lawsuit payouts won’t arrive until a settlement is reached or individual cases go to verdict. Based on the current litigation timeline, the earliest payouts could arrive in late 2027 or 2028 for cases filed in 2025 and 2026.
The payout process in mass tort cases follows a predictable pattern. Think of it like a pipeline: your claim enters one end, moves through verification, and comes out the other side as a check.
Here’s how payouts typically flow:
- Settlement announced by the court and defendant
- Claims administrator is appointed to manage the process
- Claim forms are sent to all registered plaintiffs
- Documentation review verifies injuries and device usage
- Tier assignment places each claim in a payout bracket
- Payment distribution sends funds via check or direct deposit
| Payout Factor | Impact on Your Payment |
|---|---|
| Severity of injury | Higher injury = higher tier = bigger check |
| Quality of evidence | Better documentation = fewer deductions |
| Legal fees | Attorney fees (typically 33% to 40%) deducted from settlement |
| Liens | Medical liens or insurance subrogation claims may reduce net payout |
| Claim filing timing | Earlier filers may receive priority in distribution |
Net payouts after attorney fees will be lower than the gross settlement amount. If your claim is valued at $100,000 and your attorney takes 33%, you would receive approximately $67,000 before any medical liens.
Understanding this math early helps you set realistic expectations.
Key Takeaway: Dexcom lawsuit payouts could range from $5,000 for minor claims to over $2 million for wrongful death, with the earliest payments expected in late 2027 or 2028.
How to File a Dexcom Lawsuit
How to file a Dexcom lawsuit involves a straightforward process that starts with gathering your evidence and ends with retaining an attorney who specializes in medical device litigation. You don’t need to be a legal expert. You just need your records and your story.
Step-by-step filing process:
Step 1: Collect Your Evidence
- Dexcom purchase receipts or pharmacy records
- Medical records from any related ER visit, hospitalization, or doctor appointment
- Screenshots of Dexcom app data showing inaccurate readings
- Photos of skin injuries from sensors or adhesive
- Dexcom correspondence (replacement requests, complaints)
Step 2: Check Your State’s Deadline
| State | Statute of Limitations |
|---|---|
| California | 2 years from injury |
| Texas | 2 years from injury |
| Florida | 2 years from injury (changed from 4 years in 2023) |
| New York | 3 years from injury |
| Illinois | 2 years from injury |
| Other States | Typically 2 to 3 years; verify with counsel |
Step 3: Contact a Medical Device Attorney
Look for attorneys who handle medical device or mass tort cases. Most work on contingency, meaning you pay nothing upfront. They only get paid if you win.
Step 4: Case Evaluation
The attorney reviews your evidence and determines if your claim meets the threshold for filing.
Step 5: Lawsuit Filed
Your attorney files the complaint in the appropriate court. From this point, you wait for the litigation to progress while your legal team handles the work.
The entire intake process from first call to filed complaint typically takes 2 to 4 weeks. Don’t let paperwork anxiety stop you. Attorneys handle most of the heavy lifting.
Frequently Asked Questions
Is there a class action lawsuit against Dexcom in 2026?
No certified federal class action exists as of early 2026.
Most Dexcom claims are proceeding as individual lawsuits or heading toward MDL consolidation.
State-level class actions for consumer fraud claims may still emerge later this year.
How much money can I get from a Dexcom lawsuit?
Estimated payouts range from $5,000 to over $2 million depending on injury severity.
Hospitalization cases typically fall in the $75,000 to $250,000 range.
Actual amounts depend on your medical records, device data, and the final settlement terms.
What Dexcom devices are part of the lawsuit?
The Dexcom G6 and Dexcom G7 are the primary devices named in current lawsuits.
Both models have thousands of FDA adverse event reports documenting malfunctions.
Older Dexcom models may qualify in some cases, but G6 and G7 claims dominate the litigation.
What is the deadline to file a Dexcom lawsuit?
Deadlines vary by state but typically fall 2 to 3 years after the injury occurred.
Several states have a 2-year statute of limitations, including California, Texas, and Florida.
Filing sooner preserves your evidence and strengthens your position.
How long does a Dexcom lawsuit take to settle?
Medical device lawsuits typically take 2 to 5 years from filing to final payout.
Cases filed in 2026 could see settlement checks by late 2027 at the earliest, more likely 2028.
MDL consolidation and bellwether trials drive the timeline.
This is a developing story and the legal landscape is shifting fast. If you used a Dexcom G6 or G7 and experienced a malfunction or injury, the time to act is now.
Gather your medical records, your device data, and your purchase history. Contact a medical device attorney to get your claim evaluated at no cost.
Your health crisis shouldn’t be your financial burden too.
